Insider Trading disclosures for Macrogenics Inc

The latest disclosure was made by Ezio Bonvini in Macrogenics Inc where a trade of 16,665 Restricted Stock Unit done was reported to US exchanges on Feb. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ezio Bonvini	Sr VP, Research & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	16,665	-		-	Restricted Stock Unit
Ezio Bonvini	Sr VP, Research & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	124,414 (0%)	0%		0	Common Stock
Scott Koenig	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	42,329	777,415 (1%)	0%		0	Common Stock
Scott Koenig	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	42,329	42,330	-		-	Restricted Stock Unit
James Karrels	SVP, CFO and Secretary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share.	15 Feb 2025	5,790	186,801 (0%)	0%	2.6	14,822	Common Stock
James Karrels	SVP, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	14,998	14,999	-		-	Restricted Stock Unit
James Karrels	SVP, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	14,998	192,591 (0%)	0%		0	Common Stock
Eric Risser	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share.	15 Feb 2025	6,433	55,989 (0%)	0%	2.6	16,468	Common Stock
Eric Risser	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	16,665	-		-	Restricted Stock Unit
Eric Risser	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	62,422 (0%)	0%		0	Common Stock
Stephen L. Eck	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	16,665	-		-	Restricted Stock Unit
Stephen L. Eck	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share.	15 Feb 2025	4,942	29,377 (0%)	0%	2.6	12,652	Common Stock
Stephen L. Eck	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	16,665	34,319 (0%)	0%		0	Common Stock
Thomas Spitznagel	Sr VP, Technical Ops	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share.	15 Feb 2025	5,520	21,402 (0%)	0%	2.6	14,131	Common Stock
Thomas Spitznagel	Sr VP, Technical Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	13,332	13,332	-		-	Restricted Stock Unit
Thomas Spitznagel	Sr VP, Technical Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	13,332	26,922 (0%)	0%		0	Common Stock
Jeffrey Stuart Peters	Senior VP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	13,332	13,332	-		-	Restricted Stock Unit
Jeffrey Stuart Peters	Senior VP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	13,332	18,858 (0%)	0%		0	Common Stock
Jeffrey Stuart Peters	Senior VP and General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share.	15 Feb 2025	5,147	13,711 (0%)	0%	2.6	13,176	Common Stock
Beth Smith	VP, Controller & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	1,095	1,095	-		-	Restricted Stock Unit
Beth Smith	VP, Controller & Treasurer	Sale of securities on an exchange or to another person at price $ 2.56 per share.	15 Feb 2025	423	9,532 (0%)	0%	2.6	1,083	Common Stock
Beth Smith	VP, Controller & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2025	1,095	9,955 (0%)	0%		0	Common Stock
Scott Koenig	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2025	31,673	735,086 (1%)	0%		0	Common Stock
Scott Koenig	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Feb 2025	31,673	63,327	-		-	Restricted Stock Unit
Ezio Bonvini	Sr VP, Research & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	21,000	21,000	-		-	Restricted Stock Unit
Ezio Bonvini	Sr VP, Research & CSO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share.	07 Feb 2025	4,311	107,749 (0%)	0%	2.6	11,209	Common Stock
Ezio Bonvini	Sr VP, Research & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	112,060 (0%)	0%		-	Common Stock
Ezio Bonvini	Sr VP, Research & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	128,000	128,000	-		-	Employee Stock Option (right to buy)
Ezio Bonvini	Sr VP, Research & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	22,332	-		-	Restricted Stock Unit
James Karrels	SVP, CFO and Secretary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share.	07 Feb 2025	3,861	177,593 (0%)	0%	2.6	10,039	Common Stock
James Karrels	SVP, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	10,002	19,998	-		-	Restricted Stock Unit
James Karrels	SVP, CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	19,000	19,000	-		-	Restricted Stock Unit
James Karrels	SVP, CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	113,000	113,000	-		-	Employee Stock Option (right to buy)
James Karrels	SVP, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	10,002	181,454 (0%)	0%		-	Common Stock
Eric Risser	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share.	07 Feb 2025	4,311	45,757 (0%)	0%	2.6	11,209	Common Stock
Eric Risser	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	22,332	-		-	Restricted Stock Unit
Eric Risser	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	20,000	20,000	-		-	Restricted Stock Unit
Eric Risser	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	120,000	120,000	-		-	Employee Stock Option (right to buy)
Eric Risser	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	50,068 (0%)	0%		-	Common Stock
Stephen L. Eck	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	22,332	-		-	Restricted Stock Unit
Stephen L. Eck	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	11,168	20,966 (0%)	0%		0	Common Stock
Stephen L. Eck	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share.	07 Feb 2025	3,312	17,654 (0%)	0%	2.6	8,611	Common Stock
Stephen L. Eck	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	113,000	113,000	-		-	Employee Stock Option (right to buy)
Stephen L. Eck	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	19,000	19,000	-		-	Restricted Stock Unit
Thomas Spitznagel	Sr VP, Technical Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	9,001	17,999	-		-	Restricted Stock Unit
Thomas Spitznagel	Sr VP, Technical Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	9,001	17,317 (0%)	0%		-	Common Stock
Thomas Spitznagel	Sr VP, Technical Ops	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share.	07 Feb 2025	3,727	13,590 (0%)	0%	2.6	9,690	Common Stock
Thomas Spitznagel	Sr VP, Technical Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	105,000	105,000	-		-	Employee Stock Option (right to buy)
Thomas Spitznagel	Sr VP, Technical Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	18,000	18,000	-		-	Restricted Stock Unit
Jeffrey Stuart Peters	Senior VP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2025	9,001	9,001 (0%)	0%		-	Common Stock

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

High volume+loss today

Insider Trading disclosures for Macrogenics Inc

The latest disclosure was made by Ezio Bonvini in Macrogenics Inc where a trade of 16,665 Restricted Stock Unit done was reported to US exchanges on Feb. 15, 2025.

Screeners based on Insider Trading and SAST parameters